TEVA logo

TEVA Cash from investing

annual CFI:

$792.00M-$176.00M(-18.18%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual cash flow from investing activities is $792.00 million, with the most recent change of -$176.00 million (-18.18%) on December 31, 2024.
  • During the last 3 years, TEVA annual CFI has fallen by -$731.00 million (-48.00%).
  • TEVA annual CFI is now -77.02% below its all-time high of $3.45 billion, reached on December 31, 2017.

Performance

TEVA Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

quarterly CFI:

$201.00M-$1.00M(-0.50%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly cash flow from investing activities is $201.00 million, with the most recent change of -$1.00 million (-0.50%) on March 31, 2025.
  • Over the past year, TEVA quarterly CFI has increased by +$57.00 million (+39.58%).
  • TEVA quarterly CFI is now -89.49% below its all-time high of $1.91 billion, reached on December 31, 2017.

Performance

TEVA quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

TTM CFI:

$849.00M+$57.00M(+7.20%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA TTM cash flow from investing activities is $849.00 million, with the most recent change of +$57.00 million (+7.20%) on March 31, 2025.
  • Over the past year, TEVA TTM CFI has dropped by -$82.00 million (-8.81%).
  • TEVA TTM CFI is now -77.08% below its all-time high of $3.70 billion, reached on September 30, 2018.

Performance

TEVA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TEVA Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.2%+39.6%-8.8%
3 y3 years-48.0%+24.8%-27.8%
5 y5 years-41.5%-20.2%-36.4%

TEVA Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.0%+20.7%-33.4%+39.6%-27.8%+29.4%
5 y5-year-48.0%+20.7%-60.4%+42.5%-44.3%+29.4%
alltimeall time-77.0%+102.3%-89.5%+100.6%-77.1%+102.4%

TEVA Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$201.00M(-0.5%)
$849.00M(+7.2%)
Dec 2024
$792.00M(-18.2%)
$202.00M(-24.6%)
$792.00M(-11.1%)
Sep 2024
-
$268.00M(+50.6%)
$891.00M(+10.4%)
Jun 2024
-
$178.00M(+23.6%)
$807.00M(-13.3%)
Mar 2024
-
$144.00M(-52.2%)
$931.00M(-3.8%)
Dec 2023
$968.00M(+47.6%)
$301.00M(+63.6%)
$968.00M(+15.9%)
Sep 2023
-
$184.00M(-39.1%)
$835.00M(+4.6%)
Jun 2023
-
$302.00M(+66.9%)
$798.00M(+18.0%)
Mar 2023
-
$181.00M(+7.7%)
$676.00M(+3.0%)
Dec 2022
$656.00M(-56.9%)
$168.00M(+14.3%)
$656.00M(-10.6%)
Sep 2022
-
$147.00M(-18.3%)
$734.00M(-16.1%)
Jun 2022
-
$180.00M(+11.8%)
$875.00M(-25.6%)
Mar 2022
-
$161.00M(-34.6%)
$1.18B(-22.8%)
Dec 2021
$1.52B(+76.5%)
$246.00M(-14.6%)
$1.52B(+7.4%)
Sep 2021
-
$288.00M(-40.1%)
$1.42B(+10.2%)
Jun 2021
-
$481.00M(-5.3%)
$1.29B(+15.0%)
Mar 2021
-
$508.00M(+260.3%)
$1.12B(+29.7%)
Dec 2020
$863.00M(-36.3%)
$141.00M(-10.2%)
$863.00M(-25.1%)
Sep 2020
-
$157.00M(-49.8%)
$1.15B(-5.5%)
Jun 2020
-
$313.00M(+24.2%)
$1.22B(-8.7%)
Mar 2020
-
$252.00M(-41.4%)
$1.33B(-1.5%)
Dec 2019
$1.35B(-27.4%)
$430.00M(+92.0%)
$1.35B(+35.6%)
Sep 2019
-
$224.00M(-47.8%)
$999.00M(-11.0%)
Jun 2019
-
$429.00M(+57.7%)
$1.12B(+2.1%)
Mar 2019
-
$272.00M(+267.6%)
$1.10B(-41.1%)
Dec 2018
$1.87B(-45.9%)
$74.00M(-78.7%)
$1.87B(-49.6%)
Sep 2018
-
$347.00M(-14.5%)
$3.70B(+7.0%)
Jun 2018
-
$406.00M(-60.9%)
$3.46B(+16.6%)
Mar 2018
-
$1.04B(-45.7%)
$2.97B(-13.8%)
Dec 2017
$3.45B(-110.0%)
$1.91B(+1738.5%)
$3.45B(+66.3%)
Sep 2017
-
$104.00M(-220.9%)
$2.07B(-106.8%)
Jun 2017
-
-$86.00M(-105.7%)
-$30.33B(-0.5%)
Mar 2017
-
$1.52B(+181.8%)
-$30.47B(-11.4%)
Dec 2016
-$34.41B(+518.2%)
$538.00M(-101.7%)
-$34.41B(-2.4%)
Sep 2016
-
-$32.30B(>+9900.0%)
-$35.24B(+1047.4%)
Jun 2016
-
-$225.00M(-90.7%)
-$3.07B(-60.4%)
Mar 2016
-
-$2.42B(+724.9%)
-$7.76B(+39.5%)
Dec 2015
-$5.57B(+283.8%)
-$293.00M(+115.4%)
-$5.57B(-1.0%)
Sep 2015
-
-$136.00M(-97.2%)
-$5.62B(-6.5%)
Jun 2015
-
-$4.92B(+2145.2%)
-$6.01B(+369.2%)
Mar 2015
-
-$219.00M(-36.9%)
-$1.28B(-11.7%)
Dec 2014
-$1.45B(+26.4%)
-$347.00M(-34.3%)
-$1.45B(+2.2%)
Sep 2014
-
-$528.00M(+182.4%)
-$1.42B(+19.2%)
Jun 2014
-
-$187.00M(-51.8%)
-$1.19B(-6.2%)
Mar 2014
-
-$388.00M(+22.8%)
-$1.27B(+10.6%)
Dec 2013
-$1.15B(+1.1%)
-$316.00M(+5.7%)
-$1.15B(-7.5%)
Sep 2013
-
-$299.00M(+12.4%)
-$1.24B(+4.2%)
Jun 2013
-
-$266.00M(0.0%)
-$1.19B(-1.3%)
Mar 2013
-
-$266.00M(-35.0%)
-$1.21B(+6.3%)
Dec 2012
-$1.13B(-85.1%)
-$409.00M(+64.3%)
-$1.13B(-81.8%)
Sep 2012
-
-$249.00M(-11.7%)
-$6.22B(-13.2%)
Jun 2012
-
-$282.00M(+45.4%)
-$7.16B(+0.6%)
Mar 2012
-
-$194.00M(-96.5%)
-$7.12B(-6.3%)
DateAnnualQuarterlyTTM
Dec 2011
-$7.60B(+39.3%)
-$5.49B(+359.9%)
-$7.60B(+226.8%)
Sep 2011
-
-$1.19B(+397.5%)
-$2.33B(-62.7%)
Jun 2011
-
-$240.00M(-64.5%)
-$6.23B(+7.4%)
Mar 2011
-
-$676.00M(+213.0%)
-$5.80B(+6.4%)
Dec 2010
-$5.46B(+495.5%)
-$216.00M(-95.8%)
-$5.46B(-0.9%)
Sep 2010
-
-$5.10B(-2798.4%)
-$5.50B(+645.5%)
Jun 2010
-
$189.00M(-157.6%)
-$738.00M(-33.0%)
Mar 2010
-
-$328.00M(+24.7%)
-$1.10B(+20.3%)
Dec 2009
-$916.00M(-77.9%)
-$263.00M(-21.7%)
-$916.00M(-79.7%)
Sep 2009
-
-$336.00M(+92.0%)
-$4.51B(+4.2%)
Jun 2009
-
-$175.00M(+23.2%)
-$4.33B(-1.5%)
Mar 2009
-
-$142.00M(-96.3%)
-$4.39B(+6.2%)
Dec 2008
-$4.14B(+205.8%)
-$3.86B(+2403.9%)
-$4.14B(+481.9%)
Sep 2008
-
-$154.00M(-36.4%)
-$711.00M(-9.0%)
Jun 2008
-
-$242.00M(-310.4%)
-$781.00M(+44.4%)
Mar 2008
-
$115.00M(-126.7%)
-$541.00M(-60.0%)
Dec 2007
-$1.35B(-66.7%)
-$430.00M(+92.0%)
-$1.35B(+52.1%)
Sep 2007
-
-$224.00M(>+9900.0%)
-$889.30M(-28.3%)
Jun 2007
-
-$2.00M(-99.7%)
-$1.24B(-21.0%)
Mar 2007
-
-$697.00M(-2168.2%)
-$1.57B(-61.3%)
Dec 2006
-$4.06B(+654.3%)
$33.70M(-105.9%)
-$4.06B(-1.7%)
Sep 2006
-
-$575.20M(+73.0%)
-$4.13B(+5.5%)
Jun 2006
-
-$332.50M(-89.6%)
-$3.91B(+7.0%)
Mar 2006
-
-$3.18B(+8623.3%)
-$3.66B(+579.9%)
Dec 2005
-$538.00M(-77.5%)
-$36.50M(-89.9%)
-$538.00M(-42.6%)
Sep 2005
-
-$361.20M(+375.3%)
-$936.70M(+41.2%)
Jun 2005
-
-$76.00M(+18.2%)
-$663.30M(-17.3%)
Mar 2005
-
-$64.30M(-85.2%)
-$801.70M(-66.5%)
Dec 2004
-$2.39B(+450.0%)
-$435.20M(+395.7%)
-$2.39B(+23.6%)
Sep 2004
-
-$87.80M(-59.0%)
-$1.94B(-5.9%)
Jun 2004
-
-$214.40M(-87.1%)
-$2.06B(+3.1%)
Mar 2004
-
-$1.66B(-7591.4%)
-$1.99B(+358.3%)
Dec 2003
-$435.10M(-34.6%)
$22.10M(-110.6%)
-$435.10M(-11.0%)
Sep 2003
-
-$208.40M(+36.8%)
-$488.80M(-12.3%)
Jun 2003
-
-$152.30M(+57.8%)
-$557.50M(-6.0%)
Mar 2003
-
-$96.50M(+205.4%)
-$593.20M(-10.8%)
Dec 2002
-$664.90M(+248.7%)
-$31.60M(-88.6%)
-$664.90M(-5.4%)
Sep 2002
-
-$277.10M(+47.4%)
-$702.55M(+51.1%)
Jun 2002
-
-$188.00M(+11.8%)
-$464.92M(+41.1%)
Mar 2002
-
-$168.20M(+142.9%)
-$329.38M(+72.8%)
Dec 2001
-$190.65M(+126.1%)
-$69.25M(+75.5%)
-$190.65M(+57.0%)
Sep 2001
-
-$39.47M(-24.8%)
-$121.40M(+48.2%)
Jun 2001
-
-$52.46M(+78.0%)
-$81.93M(+178.0%)
Mar 2001
-
-$29.47M
-$29.47M
Dec 2000
-$84.31M(-69.0%)
-
-
Dec 1999
-$271.87M(+104.2%)
-
-
Dec 1998
-$133.11M(+104.2%)
-
-
Dec 1997
-$65.20M(-48.7%)
-
-
Dec 1996
-$127.00M(-0.2%)
-
-
Dec 1995
-$127.30M(+48.2%)
-
-
Dec 1994
-$85.90M(+57.3%)
-
-
Dec 1993
-$54.60M(+22.4%)
-
-
Dec 1992
-$44.60M(-7.7%)
-
-
Dec 1991
-$48.30M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?

The current annual CFI of TEVA is $792.00M

What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cash flow from investing activities is $3.45B

What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?

Over the past year, TEVA annual cash flow from investing activities has changed by -$176.00M (-18.18%)

What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?

The current quarterly CFI of TEVA is $201.00M

What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from investing activities is $1.91B

What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?

Over the past year, TEVA quarterly cash flow from investing activities has changed by +$57.00M (+39.58%)

What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?

The current TTM CFI of TEVA is $849.00M

What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cash flow from investing activities is $3.70B

What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?

Over the past year, TEVA TTM cash flow from investing activities has changed by -$82.00M (-8.81%)
On this page